KCT0007091Recruiting
Untitled Trial
Open-label Phase II Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer(GENUINE)
Yonsei University Health System, Severance HospitalPhase 2Korean Clinical Trial Registry
VerifiedKorean Clinical Trial Registry
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Yonsei University Health System, Severance Hospital
- Funder
- Genexine
- Location
- South Korea
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- Korean Clinical Trial Registry
- Trial ID
- KCT0007091
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for KCT0007091 through Pure Global AI's free database. This Phase 2 trial is sponsored by Yonsei University Health System, Severance Hospital and is currently Recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Korean Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.